发明名称 METHOD OF DETERMINING RISK OF ATRIUM FIBRILLATION DEVELOPMENT
摘要 FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to cardiology. ECG examination is performed to patient. Registration of signal-averaged ECG and transesophageal electrocardiostimulation (TE ECS) are carried out. Duration of filtered wave "P" (FiP-P) of signal-averaged ECG, dispersion of wave "P" (Pd), frequency threshold of arrhythmia induction (FTAI) and its duration are determined by means of TE ECS, risk of atrium fibrillation development (RAFD) being determined by original mathematical formula. If RAFD values are to 0.5, high during 1-3 months risk of AF development is identified. If values are from 0.5 to 1.5 - average from 3 months to 1 year risk of AF development. If values are higher than 1.5 - low, more than 1 year risk of AF development is identified after the first examination of patient.EFFECT: method increases accuracy of determining risk of AF development after the first examination due to analysis of interaction of ECG and TEECS indices.5 tbl, 4 ex
申请公布号 RU2497446(C1) 申请公布日期 2013.11.10
申请号 RU20120129470 申请日期 2012.07.11
申请人 GOSUDARSTVENNOE BJUDZHETNOE OBRAZOVATEL'NOE UCHREZHDENIE VYSSHEGO PROFESSIONAL'NOGO OBRAZOVANIJA "SEVERO-ZAPADNYJ GOSUDARSTVENNYJ MEDITSINSKIJ UNIVERSITET IM. I.I. MECHNIKOVA" MINISTERSTVA ZDRAVOOKHRANENIJA I SOTSIAL'NOGO RAZVITIJA ROSSIJSKOJ FEDERATSII 发明人 OLESIN ALEKSANDR IOSIFOVICH;PROSJANIKOVA OKSANA NIKOLAEVNA
分类号 A61B5/0452 主分类号 A61B5/0452
代理机构 代理人
主权项
地址
您可能感兴趣的专利